Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study

Journal of Diabetes

Volumn 8, Issue 1, 2016, Pages 139-147

  Tan, Eva D D ^a   Davis, Wendy A ^a   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anglo Celt ethnicity; Asian ethnicity; Cardiovascular risk factors; Type 2 diabetes; Vascular complications

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANGLO-CELT (PEOPLE); ARTICLE; ASIAN; AUSTRALIA; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FOLLOW UP; HYPERTENSION; MIGRANT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SENSORY NEUROPATHY; URBAN POPULATION; WAIST CIRCUMFERENCE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CAUCASIAN; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE MANAGEMENT; FEMALE; HUMAN; MALE; MIDDLE AGED; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREVALENCE; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; CARDIOVASCULAR DISEASES; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE MANAGEMENT; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TIME FACTORS; URBAN POPULATION;

EID: 84953851054     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12267     Document Type: Article

References (40)

1. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: Retrospective cohort study. BMJ. 2009; 338: b1870.
2. Davis TME, Hunt K, McAullay D etal. Continuing disparities in cardiovascular risk factors and complications between Aboriginal and Anglo-Celt Australians with type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care. 2012; 35: 2005-2011.
3. Dodd AH, Colby MS, Boye KS, Fahlman C, Kim S, Briefel RR. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004. Curr Med Res Opin. 2009; 25: 1605-1613.
4. Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: Findings from the National Health and Nutrition Examination Survey 1999-2008. J Diabetes. 2011; 3: 337-347.
5. Ford ES. Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: Findings from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care. 2011; 34: 1337-1343.
6. Australian Government, Department of Immigration and Citizenship. Historical Migration Statistics. 2013. Available from: http://www.immi.gov.au/media/statistics/historical-migration-stats.htm (accessed February 2014).
7. Tan ED, Davis WA, Davis TM. Characteristics and prognosis of Asian patients with type 2 diabetes from a multi-racial Australian community: The Fremantle Diabetes Study. Intern Med J. 2013; 43: 1125-1132.
8. Davis TM, Bruce DG, Davis WA. Cohort profile: The Fremantle Diabetes Study. Int J Epidemiol. 2013; 42: 412-421.
9. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. 2005. Available from: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf (accessed February 2014).
10. World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363: 157-163.
11. Norman PE, Davis WA, Bruce DG, Davis TM. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Care. 2006; 29: 575-580.
12. Feldman E, Stevens M, Thomas P, Brown M, Canal N, Greene D. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994; 17: 1281-1289.
13. Levey AS, Stevens LA, Schmid CH etal. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612.
14. Davis WA, Knuiman MW, Davis TME. An Australian cardiovascular risk equation for type 2 diabetes: The Fremantle Diabetes Study. Intern Med J. 2010; 40: 286-292.
15. Juul S. EpiBasic. Simple Statistical Tools for Epidemiological Analysis. 2006. Available from: www.speam.dk/files/2/epibasic.xls (accessed February 2014).
16. Gholap N, Davies M, Patel K, Sattar N, Khunti K. Type 2 diabetes and cardiovascular disease in South Asians. Primary Care. Diabetes. 2011; 5: 45-56.
17. Barnett AH, Dixon AN, Bellary S etal. Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia. 2006; 49: 2234-2246.
18. Chiu M, Austin PC, Manuel DG, Shah BR, Deriving TJV. ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011; 34: 1741-1748.
19. Haffner SM. Epidemiology of type 2 diabetes: Risk factors. Diabetes Care. 1998; 21 (Suppl. 3): C3-6.
20. Mohan V, Sharp P, Cloke H, Burrin J, Schumer B, Kohner E. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia. 1986; 29: 235-237.
21. Chan J, Malik V, Jia W etal. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301: 2129-2140.
22. Nakagami T, Qiao Q, Carstensen B etal. Age, body mass index and type 2 diabetes: Associations modified by ethnicity. Diabetologia. 2003; 46: 1063-1070.
23. Australian Bureau of Statistics. National Health Survey: Summary of Results, 2007-2008. Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4364.0Main+Features12007-2008%20%28Reissue%29?OpenDocument (accessed February 2014).
24. Yoon KH, Lee JH, Kim JW etal. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006; 368: 1681-1688.
25. Davis TM, Cull CA. Holman RR for the UKPDS Group. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55). Diabetes Care. 2001; 24: 1167-1174.
26. Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: The effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract. 2002; 57: 45-51.
27. Raymond N, Varadhan L, Reynold D etal. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with White Europeans in the community. Diabetes Care. 2009; 32: 410-415.
28. Thomas RL, Distiller L, Luzio SD etal. Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa. Diabetes Care. 2013; 36: 336-341.
29. Davis TM, Coleman RL. Holman RR for the UKPDS Group. Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83). Diabet Med. 2014; 31: 200-207.
30. Yuan MX, Peng ZH, Xin Z etal. Low prevalence of diabetic retinopathy in a Chinese population. Diabetes Care. 2012; 35: e61.
31. Barbour SJ, Schachter M, Er L, Djurdjev O, Levin A. A systematic review of ethnic differences in the rate of renal progression in CKD patients. Nephrol Dial Transplant. 2010; 25: 2422-2430.
32. Dreyer G, Hull S, Mathur R, Chesser A, Yaqoob MM. Progression of chronic kidney disease in a multi-ethnic community cohort of patients with diabetes mellitus. Diabet Med. 2013; 30: 956-963.
33. Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med. 1998; 15: 672-677.
34. Australian Government, Department of Immigration and Border Protection. Medical Examination for an Australian Visa. 2014. Available from: http://www.immi.gov.au/allforms/pdf/26.pdf (accessed February 2014).
35. Winkley K, Thomas SM, Sivaprasad S etal. The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: The South London Diabetes cohort (SOUL-D). Diabetologia. 2013; 56: 1272-1281.
36. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011; 34: 2220-2224.
37. Abbott CA, Chaturvedi N, Malik RA etal. Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans. Diabetes Care. 2010; 33: 1325-1330.
38. Liu J, Hong Y, D'Agostino RB Sr etal. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004; 291: 2591-2599.
39. Yang X, So WY, Kong AP etal. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am J Cardiol. 2008; 101: 596-601.
40. Zaman MJ, Philipson P, Chen R etal. South Asians and coronary disease: Is there discordance between effects on incidence and prognosis? Heart. 2013; 99: 729-736.